The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Versant Vantage I Gp-gp, Llc since 2019.
This trader's CIK number is 1777653.
At the time of last reporting, Versant Vantage I Gp-gp, Llc was the Officer of Monte Rosa Therapeutics, Inc.. (stock ticker symbol GLUE).
Also see all insider trading activities at Monte Rosa Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | RPTX | 0 | $0 | 750,000 | $9,189,000 | 0 | $0 |
| 2020 | RPTX | 250,000 | $5,000,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | GLUE | 0 | $0 | 1,857,674 | $12,297,510 | 0 | $0 |
| 2021 | GLUE | 157,895 | $3,000,005 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | APRE | 333,333 | $4,999,995 | 0 | $0 | 0 | $0 |
1. Repare Therapeutics Inc. (RPTX)
2. Monte Rosa Therapeutics, Inc. (GLUE)
3. Aprea Therapeutics, Inc. (APRE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-03 | RPTX | Sale | 750,000 | 12.25 | 9,189,000 |
| 2020-06-23 | RPTX | Buy | 250,000 | 20.00 | 5,000,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-28 | GLUE | Sale | 89,990 | 9.66 | 869,213 |
| 2024-10-29 | GLUE | Sale | 67,905 | 9.25 | 627,849 |
| 2024-09-20 | GLUE | Sale | 1,132,566 | 6.53 | 7,395,655 |
| 2024-09-13 | GLUE | Sale | 9,269 | 6.16 | 57,097 |
| 2024-09-11 | GLUE | Sale | 541,897 | 6.00 | 3,251,382 |
| 2024-09-12 | GLUE | Sale | 16,047 | 6.00 | 96,314 |
| 2021-06-28 | GLUE | Buy | 157,895 | 19.00 | 3,000,005 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-10-07 | APRE | Buy | 333,333 | 15.00 | 4,999,995 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Versant Vantage I Gp-gp, Llc (Officer of Monte Rosa Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.